Latest Insider Transactions at Tarsus Pharmaceuticals, Inc. (TARS)
This section provides a real-time view of insider transactions for Tarsus Pharmaceuticals, Inc. (TARS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tarsus Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tarsus Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
6,000
-0.72%
|
$300,000
$50.0 P/Share
|
|
Mar 20
2025
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,365
-4.92%
|
$168,250
$50.11 P/Share
|
|
Mar 20
2025
|
Jeffrey S Farrow Officer |
SELL
Open market or private sale
|
Direct |
1,186
-5.02%
|
$59,300
$50.11 P/Share
|
|
Mar 20
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
8,534
-13.73%
|
$426,700
$50.11 P/Share
|
|
Mar 20
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,137
-4.41%
|
$106,850
$50.11 P/Share
|
|
Mar 20
2025
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
3,084
-5.63%
|
$154,200
$50.11 P/Share
|
|
Mar 20
2025
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,435
-2.97%
|
$121,750
$50.11 P/Share
|
|
Mar 19
2025
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,557
-4.94%
|
$167,179
$47.4 P/Share
|
|
Mar 19
2025
|
Jeffrey S Farrow Officer |
SELL
Open market or private sale
|
Direct |
1,254
-5.04%
|
$58,938
$47.4 P/Share
|
|
Mar 19
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
8,551
-12.09%
|
$401,897
$47.4 P/Share
|
|
Mar 19
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,259
-4.45%
|
$106,173
$47.4 P/Share
|
|
Mar 19
2025
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
3,261
-5.62%
|
$153,267
$47.4 P/Share
|
|
Mar 19
2025
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,543
-3.0%
|
$119,521
$47.4 P/Share
|
|
Mar 18
2025
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,643
-4.82%
|
$167,578
$46.29 P/Share
|
|
Mar 18
2025
|
Jeffrey S Farrow Officer |
SELL
Open market or private sale
|
Direct |
1,284
-4.91%
|
$59,064
$46.29 P/Share
|
|
Mar 18
2025
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
7,131
-9.16%
|
$328,026
$46.29 P/Share
|
|
Mar 18
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,315
-4.36%
|
$106,490
$46.29 P/Share
|
|
Mar 18
2025
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
3,341
-5.44%
|
$153,686
$46.29 P/Share
|
|
Mar 18
2025
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,605
-2.99%
|
$119,830
$46.29 P/Share
|
|
Mar 15
2025
|
Dianne C. Whitfield Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,885
+26.25%
|
-
|
|
Mar 15
2025
|
Bobak R. Azamian President/CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
51,395
+39.77%
|
-
|
|
Mar 15
2025
|
Jeffrey S Farrow Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,019
+23.47%
|
-
|
|
Mar 15
2025
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,957
+21.7%
|
-
|
|
Mar 15
2025
|
Seshadri Neervannan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,264
+19.59%
|
-
|
|
Mar 15
2025
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
19,213
+23.83%
|
-
|
|
Mar 07
2025
|
Andrew D. Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+34.4%
|
$84,000
$12.89 P/Share
|
|
Sep 30
2024
|
Scott W Morrison Director |
SELL
Bona fide gift
|
Direct |
6,016
-100.0%
|
-
|
|
Sep 15
2024
|
Scott W Morrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+18.14%
|
-
|
|
Aug 12
2024
|
William J Phd Link |
SELL
Open market or private sale
|
Indirect |
35,000
-92.83%
|
$910,000
$26.27 P/Share
|
|
Aug 12
2024
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Direct |
27,116
+13.96%
|
-
|
|
Aug 12
2024
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
10,446
+50.0%
|
-
|
|
Aug 12
2024
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
74,892
-68.15%
|
-
|
|
Jun 24
2024
|
William J Phd Link |
BUY
Exercise of conversion of derivative security
|
Direct |
3,350
+2.34%
|
-
|
|
Jun 24
2024
|
Andrew D. Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,350
+34.54%
|
-
|
|
Jun 24
2024
|
Rosemary A Crane Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,350
+38.51%
|
-
|
|
Jun 24
2024
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,350
+24.45%
|
-
|
|
Jun 24
2024
|
Bhaskar Chaudhuri Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,350
+38.51%
|
-
|
|
Jun 24
2024
|
Scott W Morrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,350
+41.7%
|
-
|
|
Jun 24
2024
|
Elizabeth Yeu Lin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,350
+38.51%
|
-
|
|
Jun 18
2024
|
Jeffrey S Farrow Officer |
SELL
Open market or private sale
|
Direct |
10,445
-36.55%
|
$282,015
$27.47 P/Share
|
|
Jun 17
2024
|
Jeffrey S Farrow Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,881
+49.38%
|
-
|
|
Mar 18
2024
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
10,415
-28.25%
|
$312,450
$30.6 P/Share
|
|
Mar 18
2024
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
4,436
-9.77%
|
$133,080
$30.6 P/Share
|
|
Mar 18
2024
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,766
-8.1%
|
$142,980
$30.6 P/Share
|
|
Mar 18
2024
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,879
-7.01%
|
$146,370
$30.6 P/Share
|
|
Mar 18
2024
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,314
-11.21%
|
$129,420
$30.6 P/Share
|
|
Mar 15
2024
|
Bobak R. Azamian President/CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
28,274
+43.4%
|
-
|
|
Mar 15
2024
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,038
+20.96%
|
-
|
|
Mar 15
2024
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,938
+18.02%
|
-
|
|
Mar 15
2024
|
Seshadri Neervannan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,245
+15.98%
|
-
|